By

Hudaa Croeser
WHO operational handbook on Tuberculosis Module 1: Prevention Tuberculosis Preventive Treatment The WHO operational handbook on tuberculosis: tuberculosis preventive treatment is the companion, implementation guide to the 2020 WHO guidelines on TB preventive treatment.[1] Just as these guidelines are the first to be released under the rubric of the WHO consolidated TB guidelines, this handbook...
Read More
Publication: WHO consolidated guidelines on Tuberculosis Module 1: Prevention Tuberculosis preventive treatment The 2020 recommendations for the programmatic management of TB preventive treatment are the first to be released under the rubric of WHO consolidated TB guidelines (Module 1 – Prevention). The WHO consolidated TB guidelines will gradually group all TB recommendations and will be...
Read More
New, shorter treatment to prevent TB to be rolled out in five high-burden TB countries Three-month regimen expected to prevent TB in those at highest risk of developing the disease, including people living with HIV and children under the age of five 24 March 2020 (Johannesburg, South Africa) – Today, the Aurum Institute and its...
Read More
Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria, Sanofi SA, and the Stop TB Partnership is pleased to announce a significant reduction in the price of rifapentine (Priftin®) manufactured by Sanofi SA. Read more here
Read More
Press Release Pricing Agreement Makes TB Prevention Affordable for High-Burden, Low-, Lower-Middle and Upper-Middle Income Countries Aurum Institute on behalf of the IMPAACT4TB project congratulates Unitaid, the Global Fund to Fight AIDS, Tuberculosis and Malaria and Sanofi for having reached a volume-based agreement, securing a significant price discount for rifapentine (Priftin®) Hyderabad (31 October 2019)—A...
Read More
#UNIONCONF Social Media Toolkit Below, you will find social media content to be used to share the latest news on the Pricing Agreement making TB Prevention Affordable for High-Burden, Low, Lower-Middle and Upper-Middle income countries. The IMPAACT4TB Consortium together with Unitaid, the Global Fund and Sanofi for having reached a volume-based agreement, securing a significant...
Read More
The IMPAACT4TB Consortium will be hosting a Satellite Session at the Union Conference as an introduction to a Short Course Prevention Therapy, 3HP. Looking forward to seeing you there!  
Read More
The latest WHO Global TB report  2019 was published on 20 October 2019 and has been every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in the prevention, diagnosis and treatment of the disease, at global, regional and country...
Read More
TAG, our Consortium Partner has launched the Pediatric Tuberculosis (TB) section of their  2019 Pipeline Report. This section provides an overview of the research and development of innovations for diagnosing, preventing, treating TB in children. You can now read online and download  Paediatric TB Diagnosis, Prevention, and Treatment by Lindsay McKenna
Read More
1 2 3 4 5